Matthias Eberl

7.5k citations
97 papers · 5.7k indexed · 1 hit paper · h-index 43

Matthias Eberl

89 papers receiving 5.6k citations

Hit Papers

Inhibitors of the Nonmevalonate Pathway of Isoprenoid Bio...9201999202620082017250500750

Peers

Matthias Eberl
Comparison fields: 5 of 140
  • Immunology 3.0k
  • Parasitology 365
  • Oncology 1.1k
  • Health Informatics 44
  • Biochemistry 173
Replace Jørgen A. L. Kurtzhals with:
Jørgen A. L. Kurtzhals Denmark
Ping He China
Sharon Amit Israel
Ratna B. Ray United States
Ashley M. Vaughan United States
Pei Hao China
Dermot Cox Ireland
David R. Sherman United States
Neil E. Reiner Canada
Jia‐Horng Kao Taiwan
Matthias Eberl relative to Jørgen A. L. Kurtzhals Denmark Jørgen A. L. Kurtzhals's profile →
Citations per field
00.5×8.2×
Jørgen A. L. Kurtzhals · 1×
Citations per year

Countries citing papers authored by Matthias Eberl

Since Specialization
Citations

This map shows the geographic impact of Matthias Eberl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Eberl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Eberl more than expected).

Fields of papers citing papers by Matthias Eberl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Eberl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Eberl. The network helps show where Matthias Eberl may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Matthias Eberl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthias Eberl Line = papers co-authored together Matthias Eberl links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20243
4 20233
5 20230
6 20224
7 202022
8 201952
9 20193
10 201753
11 201615
12 2015112
13 201530
14
Human gammadelta T cell responses in breast cancer patients during zoledronate therapy
20100
15 2007404
16 200759
17 200296
18 200152
19 200170
20 200196

About Matthias Eberl

Matthias Eberl is a scholar working on Immunology, Parasitology, Clinical Biochemistry, Nephrology and Pharmacology, having authored 97 papers that have together received 5.7k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (39 papers), T-cell and B-cell Immunology (36 papers), Immunotherapy and Immune Responses (23 papers), Plant biochemistry and biosynthesis (12 papers), Immune Response and Inflammation (11 papers), Pharmacological Effects of Natural Compounds (6 papers), Dialysis and Renal Disease Management (5 papers) and Parasites and Host Interactions (5 papers). The work is most often cited by research in Immunology (3.0k citations), Parasitology (365 citations), Oncology (1.1k citations), Health Informatics (44 citations) and Biochemistry (173 citations). Matthias Eberl has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Hassan Jomaa, Bernhard Moser, Martin Hintz, Jochen Wiesner, Ewald Beck, Boran Altincicek, Ann‐Kristin Kollas, Silke Sanderbrand, Armin Reichenberg and Dominique Soldati‐Favre. Their work appears in journals such as Frontiers in Immunology, The Journal of Immunology, FEBS Letters, European Journal of Immunology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026